ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Europe Specific Cancer Immunotherapy Drugs Market Key Players … – Medgadget (blog)

Europe Specific Cancer Immunotherapy Drugs Market Key Players …Medgadget (blog)Specific Cancer Immunotherapy Drugs Market provides detailed market segment level data on the Europe market. The Specific Cancer Immunotherapy Drugs …and more&nbsp… Continue reading

2017-02-23 Michael Zand NEWS

Why Are Some Patients Unresponsive to Immunotherapy? – Specialty Pharmacy Times

Why Are Some Patients Unresponsive to Immunotherapy?Specialty Pharmacy TimesImmunotherapy is a promising treatment approach in the oncology landscape, but some patients are unable to respond to the therapy. In a study published in Cancer Discovery, inv… Continue reading

2017-02-23 Michael Zand NEWS

Why Are Some Patients Unresponsive to Immunotherapy? – Specialty Pharmacy Times

Why Are Some Patients Unresponsive to Immunotherapy?Specialty Pharmacy TimesImmunotherapy is a promising treatment approach in the oncology landscape, but some patients are unable to respond to the therapy. In a study published in Cancer Discovery, inv… Continue reading

2017-02-23 Michael Zand NEWS

CRISPR Turbocharges CAR T Cells, Boosts Cancer Immunotherapy – Genetic Engineering & Biotechnology News

Continue reading

2017-02-23 Michael Zand NEWS

CRISPR Turbocharges CAR T Cells, Boosts Cancer Immunotherapy – Genetic Engineering & Biotechnology News


Genetic Engineering & Biotechnology News

CRISPR Turbocharges CAR T Cells, Boosts Cancer Immunotherapy
Genetic Engineering & Biotechnology News
CRISPR can be used to install genes, such as chimeric antigen receptor (CAR) genes, into specific parts of the genome. Presumably, when CRISPR is used to build CAR T cells, their genomic engines will run more smoothly—and rack up more trouble-free …

and more »

Continue reading

2017-02-23 Michael Zand NEWS

MIODx Licenses Key Immunotherapy Technologies from UCSF – Yahoo Finance

MIODx Licenses Key Immunotherapy Technologies from UCSFYahoo FinanceSAN JOSE, Calif., Feb. 23, 2017 /PRNewswire/ — MIODx announced today that it has signed an exclusive license for two key immunotherapy technologies from the University of California, … Continue reading

2017-02-23 Michael Zand NEWS

MIODx Licenses Key Immunotherapy Technologies from UCSF – PR Newswire (press release)

MIODx Licenses Key Immunotherapy Technologies from UCSFPR Newswire (press release)SAN JOSE, Calif., Feb. 23, 2017 /PRNewswire/ — MIODx announced today that it has signed an exclusive license for two key immunotherapy technologies from …UCSF Lic… Continue reading

2017-02-23 Michael Zand NEWS

CRISPR/Cas9: A DNA-Changing Therapy for Duchenne Muscular Dystrophy – Muscular Dystrophy News

Muscular Dystrophy NewsCRISPR/Cas9: A DNA-Changing Therapy for Duchenne Muscular DystrophyMuscular Dystrophy NewsResearchers have identified a way of changing parts of DNA sequencing to be used as a treatment for genetic diseases. The CRISPR/Cas9 thera… Continue reading

2017-02-23 Michael Zand NEWS
  • 1
  • …
  • 2,060
  • 2,061
  • 2,062
  • 2,063
  • 2,064
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Genetic Engineering & Biotechnology News

CRISPR Turbocharges CAR T Cells, Boosts Cancer Immunotherapy
Genetic Engineering & Biotechnology News
CRISPR can be used to install genes, such as chimeric antigen receptor (CAR) genes, into specific parts of the genome. Presumably, when CRISPR is used to build CAR T cells, their genomic engines will run more smoothly—and rack up more trouble-free …

and more »